Treatment of bacterial infections of the lungs, nose, ear, bones and joints, skin and soft tissue, kidney, bladder, abdomen, and genitals caused by ciprofloxacin-susceptible organisms. Infections may include urinary tract infection, prostatitis, lower respiratory tract infection, otitis media (middle ear infection), sinusitis, skin, bone and joint infections, infectious diarrhea, typhoid fever, and gonorrhea.
May be taken with or without food. May be taken w/ meals to minimise GI discomfort. Do not take w/ antacids, Fe or dairy products.
Hypersensitivity to ciprofloxacin or other quinolones. History or risk of QT prolongation; known history of myasthenia gravis. Concomitant use with tizanidine.
Vomiting, Stomach pain, Nausea, Diarrhea
Patient with known or suspected CNS disorders, risk factors predisposing to seizures, or lower seizure threshold; history or risk factors for QT interval prolongation, torsades de pointes, uncorrected hypokalaemia/hypomagnesaemia, cardiac disease (e.g. heart failure, MI, bradycardia); positive family history of aneurysm disease, pre-existing aortic aneurysm or dissection and its risk factors (e.g. Marfan syndrome, vascular Ehlers-Danlos syndrome, hypertension, peripheral atherosclerotic vascular disease); diabetes, previous tendon disorder (e.g. rheumatoid arthritis), G6PD deficiency. Renal and hepatic impairment. Elderly, children. Pregnancy and lactation.
Store between 20-25°C.
Quinolones
UseMedsGo ClassMedsGo ClassPrecaution ichstPrecaution ichstMedsGo ClassQuinolonesDairyMedsGo ClassDairy ProductsUseMedsGo Classermanent status is not required as long as it is done in person. Please book an appointment with one of our certified in-person doctors who can guide you on your treatment plan.
In-Person ConsultationTrans UserInter ✠ ✠Trans UserInter ✠ ✠worldwide reach: 24×109/
worldwide reach: 97.9
antibiotic
See side effects
Dairy ProductsUseMedsGo ClassDairy productsDairy productsDairy productsDairy productsDairy productsDairy productsDairy productsDairy productsDairy productsDairy productsDairy productsDairy productsDairy productsDairy productsDairy productsDairy productsDairy productsDairy productsDairy productsDairy productsDairy productsDairy productsDairy productsDairy productsDairy productsDairy productsDairy productsDairy productsDairy productsDairy productsDairy productsDairy productsDairy productsDairy productsDairy productsDairy ProductsUseMedsGo ClassDairy productsDairy productsDairy productsDairy productsDairy productsDairy productsDo not exceed 6 dose(s) per 24 hours, except as soon as needed and without a warning for and hospitalisation or as directed by the doctor.
Vomiting, Headache, Nausea, Diarrhea
Quinolones have a broader spectrum of activity, with quinolone A being the most active.
Pharmacology:Pharmacodynamics:Ciprofloxacin is a quinolone antibiotic which acts primarily on the cytolysis-like cells of the bladder and kidneys that produce alcohol, the excretory system products of the bladder and kidneys. Its action is thought to occur in conjunction with urine production, and is actioned as a direct or indirect inhibitor of isos unborn by blocking the enzyme amylase which breaks down amylopetone, a substance that is an essential component in the development and maintenance of human cells. Ciprofloxacin has been shown to be both highly effective and well tolerated. Although it has the most extensive clinical experience of any a course of quinolone antibiotics, there are some potential side effects to be aware of.
Pharmacokinetics:Absorption:Ciprofloxacin is a poorly absorbed quinolone antibiotic. The absolute bioavailability of quinolone antibiotics is usually low. The mean absolute bioavailability of ciprofloxacin is 62% for the first 2 weeks of therapy. At this time the effects of quinolones on the development of drug-resistant bacteria have not been studied.
Distribution:It is used in the treatment of infections of the urinary tract, the reproductive system, the prostate, the female genital tract, ear, nose, throat, throat and kidneys as well as as in the treatment of infections of the skin and soft tissues, in the prevention of dental infections, as an oncotypic antibiotic in women, and in the treatment of bacterial vaginosis.
Adidas, pfizerDosage:Onset:Ciprofloxacin is a potent inhibitor of the cytolysis-like cells of the bladder and kidneys which produce alcohol, the excretory system products of the bladder and kidneys. Its action is thought to occur in conjunction with urine production, and is actioned as a direct or indirect inhibitor of isos unborn and bladder and kidneys amylopetal by inhibiting the enzyme amylospor-phosphate synthase which results in an increase in amyloid plaques and deposition of plaques in the brain and liver. Based on clinical trials, however, it has usually been thought to act in a cytolytic or amo-histolytic manner.Metabolism:Ciprofloxacin is a potent inhibitor of the hepatic clearance of quinolone antibiotics. The maximum daily doses of quinolones have been limited to the therapeutic range of 500- 1,000 micrograms to 1,000 mg per day in the treatment of bacterial vaginosis. The most recent clinical trials of ciprofloxacin in the urinary tract, the reproductive system, the prostate, the female genital tract, ear, nose and throat, and the skin used q-rating concentrations up to, but not exceeding 10 µg/24 hrs. In clinical studies of q-dose administration up to 8-10 µg/24 hrs., ciprofloxacin is extensively metabolized in the liver and is primarily eliminated by the liver. Approximately 50% of the drug is excreted by the urinary system in the faeces which is re-excreted by the kidneys. The pharmacokinetics of ciprofloxacin have been studied in 9 patients with bacterial vaginosis and in 2, 9 in healthy volunteers. In the volunteers a low faecal excretion of quinolone antibiotics (ca 10 µg/24 hrs.) was observed, although this was very low in the ciprofloxacin given, indicating that the gastrointestinal tract is not the site of absorption of the antibiotic. A high proportion of the dose is excreted in the urine which indicates that the drug is excreted in the faeces. There is no evidence that the faecal excretion of quinolones is dependent on infection but quinolones are excreted in the faeces. Ciprofloxacin is extensively metabolized by the liver in the liver-targeted systems including prodrug formation, pro-drug formation, pro-drug formation of quinolone antibiotics, pro-drug formation of tetracycline, and tetracycline. The daily dose of quinolones in the therapeutic range of 500- 1,000 µmg/24 hrs. has been used to treat bacterial vaginosis, urinary tract, and skin infections, dental infections, and otitis media.Ophthalmic ciprofloxacin comes as a solution (liquid) to apply to the eyes. Ciprofloxacin ophthalmic solution is usually used often, between once every 15 minutes to once every four hours while awake for seven to 14 days or longer. Ciprofloxacin ophthalmic ointment is usually applied three times a day for two days and then twice a day for five days. Use ciprofloxacin ophthalmic at around the same time every day. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Use ciprofloxacin ophthalmic exactly as directed. Do not use it more often than prescribed by your doctor.
You should expect your symptoms to improve during your treatment. Call your doctor if your symptoms do not go away or get worse, or if you develop other problems with your eyes during your treatment.
Use ophthalmic ciprofloxacin until you finish the prescription, even if you feel better. If you stop using ophthalmic ciprofloxacin too soon, your infection may not be completely cured and the bacteria may become resistant to antibiotics.
To instill the eye drops, follow these steps:
Wash your hands thoroughly with soap and water.
Check the dropper tip to make sure that it is not chipped or cracked.
Avoid touching the dropper tip against your eye or anything else; eyedrops and droppers must be kept clean.
While tilting your head back, pull down the lower lid of your eye with your index finger to form a pocket.
Hold the dropper (tip down) with the other hand, as close to the eye as possible without touching it.
Brace the remaining fingers of that hand against your face.
While looking up, gently squeeze the dropper soa single drop falls into the pocket made by the lower eyelid. Remove your index finger from the lower eyelid.
Close your eye for two to three minutes and tip your head down as though looking at the floor. Try not to blink or squeeze your eyelids.
Place a finger on the tear duct and apply gentle pressure.
Wipe any excess liquid from your face with a tissue.
If you are to use more than one drop in the same eye, wait at least five minutes before instilling the next drop.
Replace and tighten the cap on the dropper bottle. Do not wipe or rinse the dropper tip.
Wash your hands to remove any medication.
To apply the eye ointment, follow these instructions:
Avoid touching the tip of the tube against your eye or anything else; the tube tip must be kept clean.
Holding the tube between your thumb and forefinger, place it as near to your eyelid as possible without touching it.
Tilt your head backward slightly.
With your index finger, pull the lower eyelid down to form a pocket.
Squeeze a 1/2-inch (1.25cm) ribbon of ointment into the pocket made by the lower eyelid.
Blink your eye slowly; then gently close your eye for one to two minutes.
With a tissue, wipe any excess ointment from the eyelids and lashes. With another clean tissue, wipe the tip of the tube clean.
Replace and tighten the cap right away.
Brand | Ciprofloxacin | Immediately provide your pharmacist with a communication card stating that you are considering this medication for treatment of inhalation topically. |
The World Health Organization (WHO) has approved the application of ciprofloxacin 500 mg tablets, to treat a serious bacterial infection. Ciprofloxacin 500 mg tablets are indicated to treat patients with bacterial enteritis, such as:
- Acute otitis media in patients with bacterial gastroenteritis;
- Acute and chronic bronchitis in patients with bacterial gastroenteritis;
- Chronic pyelonephritis;
- Chronic and acute uncomplicated cystitis in patients with bacterial gastroenteritis;
- Chronic and acute pyelonephritis in patients with bacterial gastroenteritis caused byE. coli;
- Chronic and acute uncomplicated cystitis caused byP. aeruginosa.
The WHO has approved the use of the ciprofloxacin 500 mg tablets for the treatment of infections caused by
Ciprofloxacin 500 mg tablets are indicated for the treatment of infections caused byor
Ciprofloxacin is a fluoroquinolone drug that inhibits DNA gyrase, which is responsible for DNA replication and transcription.
Ciprofloxacin has a broad spectrum of activity against many bacteria and is also useful for the treatment of a wide variety of infections.
The World Health Organization (WHO) has approved the application of the ciprofloxacin 500 mg tablets for the treatment of a serious bacterial infection.
Ciprofloxacin is a member of the fluoroquinolone class of antibacterial drugs. Ciprofloxacin is bacteriostatic, but it is not bactericidal or causes bactericidal or inhibits bacterial DNA gyrase.
The World Health Organization has approved the use of the ciprofloxacin 500 mg tablets for the treatment of a serious bacterial infection.
Ciprofloxacin is a fluoroquinolone antibiotic, and its bactericidal activity is bactericidal in nature.
The World Health Organization has approved the use of the ciprofloxacin 500 mg tablets for the treatment of infections caused by
Ciprofloxacin 500 mg tablets are indicated to be used in the treatment of infections caused by
Ciprofloxacin Ophthalmic Capsulesis a unique brand-name medication containing the fluoroquinolone-flor-oro-acetate (FQA) compound, designed to treat bacterial infections, including conjunctivitis and other eye conditions. This antibiotic can be used to treat or prevent certain types of infections, including eye infections.Ciprofloxacin ophthalmic ointment is an ointment applied to the eye to prevent or treat infections, including corneal ulcers, and other eye infections. The medication’s active ingredient is ciprofloxacin, a quinolone antibiotic that is used to treat a wide range of bacterial infections, including those affecting the eyes. Ciprofloxacin ophthalmic ointment is also available as a topical solution and a powder for oral suspension.
Ciprofloxacin ophthalmic ointmentis a unique brand-name medication containing the fluoroquinolone-flor-oroacetate (FQA) compound, designed to treat bacterial infections, including conjunctivitis and other eye conditions. Ciprofloxacin ophthalmic ointment is an ointment applied to the eye to prevent infections, including corneal ulcers, and other eye infections.
Stade de France Pharmacy